Loading...
Early Diagnostics And Licensing Deals Will Advance Neurodegenerative Treatment
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
79.5%7D
-6.3%1Y
79.5%7D
-6.3%You can edit this narrative until Aug 31 9:44 PM. Then, changes will post as Updates.